Nuroflux
PrivateLast Round
Accelerator
May 11, 2022
Total Funding Raised
$129,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nuroflux operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was an Accelerator round in May 2022.
Nuroflux is a medical device company developing a wearable to non-invasively monitor brain activity and brain blood flow for stroke patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuroflux Comparables
Compare Nuroflux with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zeit Medical | 85% | |
| Time is Brain | 84% | |
| Neuralert Technologies Inc. | 78% |
For institutional investors. Book with your work email.
Nuroflux Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 11, 2022 | ||||
| Grant | Dec 14, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nuroflux Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cerebral Palsy Alliance | Accelerator |
| NSW Government | Grant |
| Remarkable | Accelerator |
| UNSW Founders | Accelerator |
| The George Institute for Global Health | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 424% MoM, from 278 to 1.5K.
- Apr 20, 2026
Monthly visitors grew 146% MoM, from 401 to 988.
For institutional investors. Book with your work email.
Nuroflux Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nuroflux's valuation, stock price, and market status.
Is Nuroflux a public or private company?
Nuroflux is a private company.
What is the current stock price of Nuroflux?
Nuroflux is a private company, so its shares have no public market price. Caplight tracks Nuroflux's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nuroflux worth (valuation)?
Valuation information for Nuroflux is not publicly available.
Can I buy Nuroflux stock?
Nuroflux shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nuroflux's last funding round?
Nuroflux's most recent funding round was Accelerator on May 11, 2022.
Who are the main investors in Nuroflux?
Key investors in Nuroflux include Cerebral Palsy Alliance, NSW Government, Remarkable, UNSW Founders, The George Institute for Global Health.
Will Nuroflux IPO soon?
No public IPO plans have been announced for Nuroflux.
How can I track Nuroflux secondary market activity?
Caplight tracks bids, offers, and trades in Nuroflux's shares on secondary markets.